Hims & Hers Health ( (HIMS) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hims & Hers Health shares are sliding as investors lock in profits after a sharp rally and react to law firm probes into whether the board properly handled an abrupt shift away from higher-margin compounded GLP-1 drugs. The market is also revaluing the stock in light of the firm’s new, distribution-focused partnership with Novo Nordisk, which could pressure long-term margins.
The stock is now struggling to break above its 50-day moving average, a key technical resistance level that is reinforcing the downside move as traders turn more cautious. This technical ceiling, combined with uncertainty over future profitability, has intensified selling pressure and made the recent surge look increasingly unsustainable to short-term players.
More about Hims & Hers Health
YTD Price Performance: -25.59%
Average Trading Volume: 32,547,476
Technical Sentiment Signal: Sell
Current Market Cap: $5.51B
For further insights into HIMS stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.